Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
10/2003
10/28/2003US6638979 Imidamide derivatives
10/28/2003US6638970 For protecting skeletal muscles against damage resulting from trauma or subsequent to muscle or systemic diseases such as intermittent claudication, for treating shock, cardiovascular disorders, for preserving donor tissue, organs in transplants
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638947 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003CA2073353C Glycerol-derived non ionic amphiphilic compounds, a process for their preparation, corresponding intermediary compounds and compositions containing said compounds
10/23/2003WO2003087045A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003WO2003087034A1 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
10/23/2003WO2003087026A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003055848A3 Urea derivatives as vr1- antagonists
10/23/2003WO2002046128A3 Quaternary amino acids on solid supports
10/23/2003US20030199692 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
10/23/2003US20030199691 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method
10/23/2003US20030199560 Bisaryl compound and medicament for cancer treatment comprising the same
10/23/2003US20030199520 Sulfonamide hydroxamates
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003CA2482544A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003CA2482341A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/22/2003EP1354887A1 Ligands for metals and improved metal-catalyzed processes based thereon
10/22/2003EP1047665B1 Matrix metalloprotease inhibitors
10/22/2003EP0699069B9 Endothelin receptor antagonists
10/22/2003CN1451013A Nucleophile-stable thoester generating compounds, method of production and use
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1125046C Butadiene derivatives and process for preparing thereof
10/21/2003CA2098020C Anti-viral compounds
10/16/2003WO2002100347A3 Prodrugs of gaba analogs, compositions and uses thereof
10/16/2003US20030195356 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
10/16/2003US20030195200 Compounds, their preparation and use
10/16/2003US20030192132 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003CN1124272C Podophyllotoxin compound and its application in pesticide
10/15/2003CN1124270C Cyclopentene derivatives useful as antagonists of the motilin receptor
10/15/2003CN1124261C Manufacture of polyene esters and acids
10/14/2003US6632955 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003CA2184747C Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/09/2003WO2003082826A1 Substituted biaryl amides as c5a receptor modulators
10/09/2003WO2003082797A1 A low corrosive integrated process for preparing dialkyl carbonates
10/09/2003WO2003082288A1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
10/09/2003WO2003082263A1 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191309 Administering N-substituted arylsulfonylamino hydroxamic acids to a patient for the treatment of arthritis and hepatic cirrhosis
10/09/2003US20030191166 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030190298 Use as skin lightening agents
10/09/2003US20030189189 For cholesteric liquid crystal displays, decorative and security application
10/09/2003CA2479928A1 Substituted biaryl amides as c5a receptor modulators
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use
10/08/2003CN1123564C Anti-inflammatory compounds
10/07/2003US6630513 Capable of lowering plasma cholesterol levels and inhibiting abnormal cell proliferation, such as in cervical adenocarcinoma
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630308 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080042A1 Decomposition inhibitor for extracellular matrix of cartilage
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003US20030187281 Process for the recovery of a polyol from an aqueous solution
10/02/2003US20030187262 Viricides, anticancer agents
10/02/2003US20030187235 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
10/02/2003US20030186944 Novel aromatic compounds
10/01/2003EP1348703A1 Polymorph forms of fasidotril, their processes of preparation and pharmaceutical compositions containing them
10/01/2003EP1000029B1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
10/01/2003CN1446220A Method for the production of imidazo-[1,2-c] [2,3]-benzodiazepines and intermediates in production thereof
10/01/2003CN1446207A Process for preparation of baccatin Ôàó derivatives
10/01/2003CN1446197A Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
09/2003
09/30/2003US6627762 Acetal and hemiacetal ester linked propylene carbonate functional (meth)acrylic esters and method of making same
09/30/2003US6627761 Preparing a carbonate urethane compound, by reacting a hydroxy functional carbonate compound such as glycerin carbonate and a diisocyanate in base and solvent; further reacting with diamine to form curing agent for polyepoxides
09/30/2003US6627648 Pharmaceutical compositions and methods for use
09/29/2003CA2423248A1 Polymorphic forms of fasidotril, procedures for their preparation and pharmaceutical compounds that contain them
09/25/2003WO2003078438A1 Carbamates as hiv protease inhibitors
09/25/2003WO2003077828A2 Novel florfenicol-type antibiotics
09/25/2003WO2003029199A9 Benzene derivatives, process for preparing the same and use thereof
09/25/2003US20030181766 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
09/25/2003US20030181490 For therapy and prophylaxis of acquired immune deficiency syndrome (AIDS), or ARC
09/25/2003CA2478731A1 Carbamates as hiv protease inhibitors
09/25/2003CA2478048A1 Novel florfenicol-type antibiotics
09/24/2003EP1346990A1 Catalyst for synthesizing alkylene carbonates
09/24/2003EP1346972A1 Process for producing optically active halohydrin compound
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003CN1444579A 2,2-disubstituted 1,3,-dioxolanes as antitussive agents
09/24/2003CN1444578A 1,3-dioxolanes with antitussive activity
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444556A Process for preparation of fluorinated acyl fluorides and fluorinated vinyl ethers
09/24/2003CN1122030C Noved synthesis of myo-inositol phosphates
09/23/2003US6624194 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6623731 Modified amino acid compounds useful in the drug delivery of bioactive agents such as recombinant human growth hormone (rhGH); dosage units; synthesis
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076405A1 Monocyclic aroylpyridinones as antiinflammatory agents
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 183